Gateway's sale of Healthway Medical notes to third parties raises eyebrows
Singapore
AHEAD of Healthway Medical Corporation's (HMC) extraordinary general meeting (EGM) to vote on the second tranche of S$60 million convertible notes, some minority shareholders have raised concerns whether private-equity fund Gateway Partners is there to make a quick buck at their expense.
Questions have risen over why Gateway chose to sell its first tranche of S$10 million in convertible notes to third parties after Lippo-linked Gentle Care has made an offer to buy over these notes at the same price it is offering to pay for each share of HMC.
TRENDING NOW
One-third of Singapore-listed firms at risk in severe AI downturn: MAS
‘We don’t want to stay as we are’: CEO Patrick Ng builds a more resilient Huationg
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Radiant World table shows six lenders with US$870 million exposure